Research Article
Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL2 and HDL3
Table 2
Nonstandardised results.
| | Control group
() | T2DM group
() | |
| | Serum | | | | | SAA (mg/L) | 15 (7, 36) | 30 (17, 68) | 0.002 | | PON-1 (U/L) | 41,109 (5690) | 38,245 (7025) | 0.043 | | HDL2 | | | | | ApoA1 (mg/L) | 167.0 (151.0, 190.9) | 162.9 (151.0, 170.3) | 0.443 | | SAA (mg/L) | 0.4 (0.2, 0.7) | 1.0 (0.6, 2.2) | <0.001 | | PON-1 (U/L) | 293.8 (189.4, 471.5) | 331.1 (216.2, 466.7) | 0.378 | | CETP (μmol/L) | 217.1 (25.1) | 232.6 (14.1) | 0.001 | | LCAT (ratio 470/390) | 0.974 (0.049) | 0.977 (0.046) | 0.809 | | HDL3 | | | | | ApoA1 (mg/L) | 1908 (251.2) | 1926 (178.1) | 0.704 | | SAA (μg/L) | 6 (3, 13) | 13 (8, 29) | <0.001 | | PON-1 (U/L) | 9656 (4003) | 10,551 (2087) | 0.203 | | CETP (μmol/L) | 245.2 (41.2) | 279.5 (17.7) | <0.001 | | LCAT (ratio 470/390) | 0.945 (0.051) | 0.948 (0.047) | 0.833 |
|
|
Results expressed as mean (SD) or as geometric mean (interquartile range) if not normally distributed, where indicates skewed distributions.
|
